702 related articles for article (PubMed ID: 17716505)
21. Dapsone hypersensitivity syndrome in a lepromatous leprosy patient--A Case Report.
Gavilanes MC; Palacio AL; Chellini PR; Nery JA; Rego JG
Lepr Rev; 2015 Jun; 86(2):186-90. PubMed ID: 26502691
[TBL] [Abstract][Full Text] [Related]
22. [Immuno-allergic accidents with rifamipcin].
Flageul B; Wagner L; Cottenot F
Acta Leprol; 2001-2002; 12(2):71-8. PubMed ID: 12136739
[TBL] [Abstract][Full Text] [Related]
23. Gender differences in epidemiological factors associated with treatment completion status of leprosy patients in the most hyperendemic district of Nepal.
Kumar RB; Singhasivanon P; Sherchand JB; Mahaisavariya P; Kaewkungwal J; Peerapakorn S; Mahotarn K
Southeast Asian J Trop Med Public Health; 2004 Jun; 35(2):334-9. PubMed ID: 15691132
[TBL] [Abstract][Full Text] [Related]
24. HLA-B*13:01 and the dapsone hypersensitivity syndrome.
Zhang FR; Liu H; Irwanto A; Fu XA; Li Y; Yu GQ; Yu YX; Chen MF; Low HQ; Li JH; Bao FF; Foo JN; Bei JX; Jia XM; Liu J; Liany H; Wang N; Niu GY; Wang ZZ; Shi BQ; Tian HQ; Liu HX; Ma SS; Zhou Y; You JB; Yang Q; Wang C; Chu TS; Liu DC; Yu XL; Sun YH; Ning Y; Wei ZH; Chen SL; Chen XC; Zhang ZX; Liu YX; Pulit SL; Wu WB; Zheng ZY; Yang RD; Long H; Liu ZS; Wang JQ; Li M; Zhang LH; Wang H; Wang LM; Xiao P; Li JL; Huang ZM; Huang JX; Li Z; Liu J; Xiong L; Yang J; Wang XD; Yu DB; Lu XM; Zhou GZ; Yan LB; Shen JP; Zhang GC; Zeng YX; de Bakker PI; Chen SM; Liu JJ
N Engl J Med; 2013 Oct; 369(17):1620-8. PubMed ID: 24152261
[TBL] [Abstract][Full Text] [Related]
25. Dapsone hypersensitivity syndrome in an adolescent during treatment during of leprosy.
Bucaretchi F; Vicente DC; Pereira RM; Tresoldi AT
Rev Inst Med Trop Sao Paulo; 2004; 46(6):331-4. PubMed ID: 15654479
[TBL] [Abstract][Full Text] [Related]
26. Case Report: A Case of Type 1 Leprosy Reaction and Dapsone Hypersensitivity Syndrome Complicating the Clinical Course of Multibacillary Leprosy.
Craig J; MacRae C; Melvin RG; Boggild AK
Am J Trop Med Hyg; 2019 May; 100(5):1145-1148. PubMed ID: 30915953
[TBL] [Abstract][Full Text] [Related]
27. Twenty five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy.
Jing Z; Zhang R; Zhou D; Chen J
Lepr Rev; 2009 Jun; 80(2):170-6. PubMed ID: 19743621
[TBL] [Abstract][Full Text] [Related]
28. Implementation of genetic screening test to reduce the incidence of dapsone hypersensitivity syndrome among patients with leprosy in Papua, Indonesia: a study protocol.
Krismawati H; Ferdiana A; Irwanto A; Budiawan T; Imaniar C; Wahyuni T; Singh P; Mieras L; Pongtiku A
BMJ Open; 2022 May; 12(5):e057173. PubMed ID: 35545382
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of multidrug therapy in paucibacillary leprosy in Singapore.
Lim JT; Tan T
Lepr Rev; 1993 Jun; 64(2):136-42. PubMed ID: 8341116
[TBL] [Abstract][Full Text] [Related]
30. Clinical trial for uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): adverse effects approach.
Cruz RCDS; Bührer-Sékula S; Penna GO; Moraes MEA; Gonçalves HS; Stefani MMA; Penna MLF; Pontes MAA; Talhari S
An Bras Dermatol; 2018 Jun; 93(3):377-384. PubMed ID: 29924240
[TBL] [Abstract][Full Text] [Related]
31. Dapsone-induced methemoglobinemia in leprosy patients.
Kaur I; Mehta M; Agnihotri N; Dogra S; Ganguly NK
Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):247-9. PubMed ID: 11875770
[No Abstract] [Full Text] [Related]
32. Association between HLA-B*1301 and dapsone-induced hypersensitivity reactions among leprosy patients in China.
Wang H; Yan L; Zhang G; Chen X; Yang J; Li M; Shen J; Yu M; Huo R; Wang B
J Invest Dermatol; 2013 Nov; 133(11):2642-2644. PubMed ID: 23604100
[No Abstract] [Full Text] [Related]
33. Dapsone-induced photosensitivity: a rare clinical presentation.
Kar BR
Photodermatol Photoimmunol Photomed; 2008 Oct; 24(5):270-1. PubMed ID: 18811870
[TBL] [Abstract][Full Text] [Related]
34. Acute Generalized Exanthematous Pustulosis (AGEP) due to dapsone in a patient with leprosy.
Narasimharao P; Pratap DV; Suneetha S
Lepr Rev; 2009 Mar; 80(1):81-4. PubMed ID: 19472855
[No Abstract] [Full Text] [Related]
35. Delayed resolution versus treatment failure in paucibacillary leprosy patients under six months fixed duration multidrug therapy.
Job CK; Jayakumar J; Aschhoff M
Indian J Lepr; 1997; 69(2):131-42. PubMed ID: 9290964
[TBL] [Abstract][Full Text] [Related]
36. The impact of MDT implementation in the Tanzania National TB-Leprosy Programme.
Chum HJ
Lepr Rev; 1986; 57 Suppl 3():63-6. PubMed ID: 3573963
[No Abstract] [Full Text] [Related]
37. Dapsone syndrome.
Dhamija R; Kumar D; Khurana G
Trop Doct; 1995 Oct; 25(4):176-7. PubMed ID: 7502329
[No Abstract] [Full Text] [Related]
38. Monitoring the regularity of self administration of dapsone by leprosy patients.
Kumar A; Balakrishnan S
Lepr India; 1982 Oct; 54(4):664-70. PubMed ID: 7183832
[TBL] [Abstract][Full Text] [Related]
39. International open trial of uniform multi-drug therapy regimen for 6 months for all types of leprosy patients: rationale, design and preliminary results.
Kroger A; Pannikar V; Htoon MT; Jamesh A; Katoch K; Krishnamurthy P; Ramalingam K; Jianping S; Jadhav V; Gupte MD; Manickam P
Trop Med Int Health; 2008 May; 13(5):594-602. PubMed ID: 18346026
[TBL] [Abstract][Full Text] [Related]
40. Urinary tract carcinoma in leprosy patients treated with dapsone for a long period.
Hironaka K; Mizushima M; Tsuzi C; Makino H
Nephron; 1997; 76(3):358-9. PubMed ID: 9226243
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
